Back
Milestone Pharmaceuticals Vs. Aritzia Industry Stock Comparison
Sell
43
MIST
Milestone Pharmaceuticals
Last Price:
1.80
Seasonality Move:
-18.41%
Buy
55
ATZAF
Aritzia
Last Price:
35.33
Seasonality Move:
4.28%
Sell
43
Milestone Pharmaceuticals (MIST)
is a Sell
Is Milestone Pharmaceuticals a Buy, Sell or Hold?
- The current Milestone Pharmaceuticals [MIST] share price is $1.80. The Score for MIST is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- MIST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Aritzia (ATZAF)
is a Buy
Is Aritzia a Buy, Sell or Hold?
- The current Aritzia [ATZAF] share price is $35.33. The Score for ATZAF is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- ATZAF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MIST Stock Price Chart
What is Milestone Pharmaceuticals's stock price today?
-
The Milestone Pharmaceuticals share price today is $1.80
The current trend is moderately bearish and MIST is experiencing slight buying pressure.
MIST Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.04 | Buy |
Relative Strength Index (14 RSI): | 49 | Sell |
Chaikin Money Flow: | 351 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.79 - 1.93) | Sell |
Bollinger Bands (100): | (1.38 - 1.76) | Buy |
ATZAF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.8 | Buy |
Relative Strength Index (14 RSI): | 58.55 | Buy |
Chaikin Money Flow: | -2579 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.09 - 35.31) | Buy |
Bollinger Bands (100): | (31.4 - 35.6) | Buy |
MIST Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.86 | Sell |
20-day SMA: | 1.85 | Sell |
50-day SMA: | 1.68 | Buy |
200-day SMA: | 1.57 | Buy |
8-day EMA: | 1.86 | Sell |
20-day EMA: | 1.84 | Sell |
50-day EMA: | 1.73 | Buy |
200-day EMA: | 1.75 | Buy |
ATZAF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.31 | Buy |
20-day SMA: | 33.66 | Buy |
50-day SMA: | 33.36 | Buy |
200-day SMA: | 30.21 | Buy |
8-day EMA: | 35.08 | Buy |
20-day EMA: | 34.15 | Buy |
50-day EMA: | 33.54 | Buy |
200-day EMA: | 30.7 | Buy |
Milestone Pharmaceuticals Earnings Growth & MIST Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and a decrease next year of $0.20 per share.
Aritzia Earnings Growth & ATZAF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.68 per share, and an increase next year of $0.57 per share.
Milestone Pharmaceuticals Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aritzia Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |